广康生化：2025年前三季度归属于上市公司股东的净利润同比增长47.10%

Core Insights - Guangkang Biochemical reported a revenue of 549,873,806.69 yuan for the first three quarters of 2025, representing a year-on-year growth of 13.53% [2] - The net profit attributable to shareholders of the listed company was 34,848,362.42 yuan, showing a significant year-on-year increase of 47.10% [2] Financial Performance - Revenue for the first three quarters of 2025 reached approximately 549.87 million yuan, up from the previous year [2] - Net profit for the same period was around 34.85 million yuan, indicating strong growth compared to the prior year [2]